Sostelly, Alexandre <br/><br/>
Can we predict chemo-induced hematotoxicity in elderly patients treated with pegylated liposomal doxorubicin? Results of a population-based model derived from the DOGMES phase II trial of the GINECO.  [electronic resource] 

 -  Journal of geriatric oncology  Jan 2013 
 - 48-57 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1879-4076 
<br/><br/><label>Standard No.: </label>10.1016/j.jgo.2012.06.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibiotics, Antineoplastic--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Doxorubicin--adverse effects<br/>Female<br/>Frail Elderly<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Hematinics--administration & dosage<br/>Humans<br/>Models, Biological<br/>Neutropenia--chemically induced<br/>Polyethylene Glycols--adverse effects<br/>Prospective Studies